WASHINGTON, United States (AFP) — Novavax said Thursday its Covid vaccine was 82 percent effective among adolescents during the period when the Delta variant was dominant, and the US biotech now plans to submit for regulatory approval in this age group. The two-dose vaccine, which is based on synthetic proteins that mimic the spikes that dot the surface of the virus, was found to be safe and effective among more than 2,200 adolescents aged […]
Tag: Novavax
WHO approves Novavax as 10th authorized Covid jab
GENEVA, Switzerland (AFP) — The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light. The European Medicines Agency had assessed and approved Nuvaxovid on Monday. It is made from a more conventional technology than others already approved, which has led officials in Brussels to express hope that this will help persuade those hesitant about […]
EU set to back Novavax Covid vaccine
by Danny KEMP THE HAGUE, Netherlands (AFP) — The EU’s drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy. Novavax’s jab, a protein-based vaccine of the kind used around the world to protect against many childhood illnesses, would be the fifth coronavirus shot authorized for the European Union. Approval would also be a boost for […]
Novavax files for EU Covid vaccine approval
by Jan HENNOP THE HAGUE, Netherlands (AFP) — Pharmaceutical giant Novavax has applied for authorization for their coronavirus vaccine in the EU with a decision possible “within weeks”, Europe’s drugs regulator said Wednesday. The jab, if approved, would be the fifth authorized for use within the EU — the other four are made by Pfizer/BioNTech, AstraZeneca/Oxford, Moderna and Johnson & Johnson. The assessment of the vaccine, which goes under the brand name Nuvaxovid, would be […]
Japan orders 150 million doses of Novavax Covid vaccine
TOKYO, Japan (AFP) — Japan has agreed to buy 150 million doses of Novavax’s coronavirus vaccine, with Japanese firm Takeda expecting to manufacture the formula for distribution early next year, the drugmaker said Tuesday. The cost of the deal was not announced, and it is contingent on the vaccine being approved in Japan. Takeda will be in charge of carrying out local clinical trials. So far, Japan has approved the Pfizer/BioNTech, Moderna and AstraZeneca jabs, […]
PHL to get “at least 70M doses” of COVID vaccines from US, including 40M Pfizer doses – PH envoy
US also donating close to a million vaccine doses to the PHL set to arrive by July https://youtu.be/2_0XQHlDvSk (Eagle News) – The Philippines will be receiving at least 70 million doses of COVID-19 vaccines from the United States, including the 40 million Pfizer doses that were finalized through a bilateral deal, according to Philippine Ambassador to the US Jose Manuel “Babe” Romualdez. In an interview with the Eagle News Service program Balitalakayan on […]
Covid-19 vaccine more than 90 percent effective: Novavax
WASHINGTON, United States (AFP) — Novavax’s Covid-19 jab is more than 90 percent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study. The jab “demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall,” the company said in a statement, adding “the study enrolled 29,960 participants across 119 sites in the U.S. and Mexico to evaluate efficacy, safety and immunogenicity.” The Maryland-headquartered company said it intended to […]
Novavax developing combination flu, Covid vaccine
WASHINGTON, United States (AFP) — US biotech firm Novavax on Monday said it had positive results from preclinical studies of a shot combining its influenza and Covid vaccine candidates. The company said a study, which it has posted to a preprint server and will now undergo peer review, showed that the shot produced strong levels of antibodies against both diseases in ferrets and hamsters. “Despite low rates during the Covid-19 pandemic, influenza remains a significant […]
Novavax firms up deal with Covax for first 350 mn jabs
by Robin MILLARD GENEVA, Switzerland (AFP) — Novavax has inked a deal for the first 350 million of its Covid-19 vaccine doses bound for the Covax global vaccine-sharing facility, the US biotech firm said Thursday. Novavax, which signed a memorandum of understanding in February to provide 1.1 billion doses in total, penned an advance purchase agreement with Covax for the first tranche. They will be supplied, subject to regulatory approval, from the third quarter of […]
Novavax Covid vaccine highly effective against severe Covid: company
WASHINGTON, United States (AFP) — US biotech firm Novavax’s Covid-19 vaccine was shown to be 100 percent protective against severe cases of the disease, including hospitalization and death, the company said Thursday following trials. But its efficacy against the South African variant fell markedly when including mild and moderate cases, results showed. The results announced Thursday were from final analyses, following interim results that were announced in late January. In a Phase 3 trial in […]
Novavax hopes to file for US vaccine approval in 2nd quarter of 2021
WASHINGTON, United States (AFP) — US biotech company Novavax said Monday it hopes to file for British approval of its Covid-19 vaccine at the start of the second quarter of 2021, and to do the same soon after in the United States. The company has no assurance that US authorities will agree to consider the request, which currently is based on results from Phase 3 clinical trials led in the Britain. Similar trials are still […]
Novavax says Covid-19 vaccine has 89% efficacy in major trial
WASHINGTON, United States (AFP) — US biotech firm Novavax said its Covid-19 vaccine candidate showed 89.3 efficacy in a major phase 3 clinical trial involving more than 15,000 people. “NVX-CoV2373 has the potential to play an important role in solving this global public health crisis,” said the company’s president and CEO Stanley Erck. But the positive news was offset by results that showed it was much less effective against a highly transmissible variant of the […]





